Revelation Biosciences (REVB) Net Equity Issued and Repurchased (2020 - 2026)
Revelation Biosciences (REVB) reported Net Equity Issued and Repurchased of -$33,802 for Q2 2026.
Powered by 
Analysis
Revelation Biosciences (REVB) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Revelation Biosciences' Net Equity Issued and Repurchased came in at $12.36 million; for FY2025, it was $9.08 million, up 22.2% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $7.43 million in FY2024 (-47.0%), $14.03 million in FY2023, $5,087 in FY2022 (-99.2%) and $599,996 in FY2021 (-90.2%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$41,166 in Q4 2025 and a high of $14.03 million in Q1 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.7 million (Q1 2026), -$41,166 (Q4 2025) and $5.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | -33,802.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33,802.00 |
| Mar 31, 2026 | 6.70 Mn |
| Dec 31, 2025 | -41,166.00 |
| Sep 30, 2025 | 5.74 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Mar 31, 2023 | 14.03 Mn |
| Mar 31, 2022 | 5,087.00 |
| Mar 31, 2021 | 599,996.00 |
| Dec 31, 2020 | 2.95 Mn |
API Access
Revelation Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();